AI Terminal
Equasens
Report Publication Announcement • Dec 10, 2025
1292_iss_2025-12-10_b88dfed0-e3df-4552-8db8-c392051cccf6.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year.
| Events | Dates |
|---|---|
| 2025 annual revenue | February 5, 2026 (after market close) |
| 2025 annual results | March 30, 2026 (before market opens) |
| 2026 Q1 revenue | April 29, 2026 (after market close) |
| Annual General Meeting | June 25, 2026 |
| 2026 Half-year revenue | July 30, 2026 (after market close) |
| 2026 Half-year results | September 28, 2026 (before market opens) |
| 2026 Q3 revenue | October 29, 2026 (after market close) |
About the Equasens Group
Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.400 people across Europe.
Equasens Group's specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.
And reflecting the spirit of its tagline "Technology for a More Human Experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.
Listed on Euronext Paris™ - Compartment B Indices: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion .
Listed on Euronext Tech Leaders and the European Rising Tech label Eligible for the Deferred Settlement Service (SRD) and the PEA-PME scheme. ISIN: FR 0012882389 – Ticker symbol: EQS
Find all the latest news about the Equasens Group at www.equasens.com and on LinkedIn
Contact
EQUASENS Group
Investor Relations
Chief Financial Officer: Frédérique
SCHMIDT
Tel.: +33 (0)3 83 15 90 67
NewCap
Investor Relations
Thomas Grojean Louis-Victor Delouvrier
Tel: +33 (0)1 44 71 94 94 [email protected]
NewCap
Financial Media Relations
Nicolas Mérigeau
Tel: +33 (0)1 44 71 94 94 [email protected]
2/2